The clinical status of cartilage tissue regeneration in humans

Osteoarthritis and Cartilage

Volumn 21, Issue 12, 2013, Pages 1824-1833

  Mollon, B ^a   Kandel, R ^b   Chahal, J ^c,d   Theodoropoulos, J ^b,d  

^a UNIVERSITY OF TORONTO   (Canada)

^b MOUNT SINAI HOSPITAL   (Canada)

^c UNIVERSITY HEALTH NETWORK   (Canada)

^d UNIVERSITY OF TORONTO   (Canada)

Author keywords

Autologous chondrocyte implantation; Cartilage; Chondrocytes; Tissue engineering

Indexed keywords

BIOMATERIAL; BONE MORPHOGENETIC PROTEIN; COLLAGEN; FIBROBLAST GROWTH FACTOR; HYALURONIC ACID; SOMATOMEDIN; TISSUE SCAFFOLD; TRANSFORMING GROWTH FACTOR BETA;

ALLOGRAFT; ARTHROSCOPIC SURGERY; ARTICULAR CARTILAGE; AUTOGRAFT; CARTILAGE CELL; CARTILAGE DEGENERATION; CARTILAGE GRAFT; CELL GROWTH; CELL POPULATION; CHONDROCYTE IMPLANTATION; CHONDROPLASTY; CLINICAL MEDICINE; COST EFFECTIVENESS ANALYSIS; EMBRYONIC STEM CELL; HUMAN; HYALINE CARTILAGE; HYDROGEL; MESENCHYMAL STEM CELL; MICROFRACTURE; NONHUMAN; PLURIPOTENT STEM CELL; PRIORITY JOURNAL; REVIEW; SURGICAL TECHNIQUE; TISSUE ENGINEERING; TISSUE REGENERATION;

AUTOLOGOUS CHONDROCYTE IMPLANTATION; CARTILAGE; CHONDROCYTES; TISSUE ENGINEERING;

ARTHROSCOPY; CARTILAGE DISEASES; CARTILAGE, ARTICULAR; CELL TRANSPLANTATION; CHONDROCYTES; EMBRYONIC STEM CELLS; GUIDED TISSUE REGENERATION; HUMANS; HYALINE CARTILAGE; MESENCHYMAL STROMAL CELLS; TISSUE ENGINEERING; TRANSPLANTATION, AUTOLOGOUS;

EID: 84888876585     PISSN: 10634584     EISSN: 15229653     Source Type: Journal    
DOI: 10.1016/j.joca.2013.08.024     Document Type: Review

References (100)

1. Mithoefer K. Complex articular cartilage restoration. Sports Med Arthrosc Rev 2013, 21(1):31-37.
2. Heinegard D. Proteoglycans and more-from molecules to biology. Int J Exp Pathol 2009, 90(6):575-586.
3. Adams M.A., Dolan P., McNally D.S. The internal mechanical functioning of intervertebral discs and articular cartilage, and its relevance to matrix biology. Matrix Biol J Int Soc Matrix Biol 2009, 28(7):384-389.
4. Buckwalter J.A., Mankin H.J., Grodzinsky A.J. Articular cartilage and osteoarthritis. Instr Course Lect 2005, 54:465-480.
5. Allan K.S., Pilliar R.M., Wang J., Grynpas M.D., Kandel R.A. Formation of biphasic constructs containing cartilage with a calcified zone interface. Tissue Eng 2007, 13(1):167-177.
6. Williamson A.K., Chen A.C., Masuda K., Thonar E.J., Sah R.L. Tensile mechanical properties of bovine articular cartilage: variations with growth and relationships to collagen network components. JOrthop Res 2003, 21(5):872-880.
7. Williamson A.K., Chen A.C., Sah R.L. Compressive properties and function-composition relationships of developing bovine articular cartilage. JOrthop Res 2001, 19(6):1113-1121.
8. Hunziker E.B. Articular cartilage repair: basic science and clinical progress. A review of the current status and prospects. Osteoarthritis Cartilage 2002, 10(6):432-463.
9. Widuchowski W., Lukasik P., Kwiatkowski G., Faltus R., Szyluk K., Widuchowski J., et al. Isolated full thickness chondral injuries. Prevalance and outcome of treatment. A retrospective study of 5233 knee arthroscopies. Acta Chir Orthop Traumatol Cech 2008, 75(5):382-386.
10. Bedi A., Feeley B.T., Williams R.J. Management of articular cartilage defects of the knee. JBone Joint Surg Am 2010, 92(4):994-1009.
11. Mikos A.G., Herring S.W., Ochareon P., Elisseeff J., Lu H.H., Kandel R., et al. Engineering complex tissues. Tissue Eng 2006, 12(12):3307-3339.
12. Franke O., Durst K., Maier V., Goken M., Birkholz T., Schneider H., et al. Mechanical properties of hyaline and repair cartilage studied by nanoindentation. Acta Biomater 2007, 3(6):873-881.
13. Widuchowski W., Widuchowski J., Trzaska T. Articular cartilage defects: study of 25,124 knee arthroscopies. Knee 2007, 14(3):177-182.
14. Williams S.K., Amiel D., Ball S.T., Allen R.T., Wong V.W., Chen A.C., et al. Prolonged storage effects on the articular cartilage of fresh human osteochondral allografts. JBone Joint Surg Am 2003, 85-A(11):2111-2120.
15. Gross A.E., Kim W., Las H.F., Backstein D., Safir O., Pritzker K.P. Fresh osteochondral allografts for posttraumatic knee defects: long-term followup. Clin Orthopaedics Relat Res 2008, 466(8):1863-1870.
16. Koh J.L., Wirsing K., Lautenschlager E., Zhang L.O. The effect of graft height mismatch on contact pressure following osteochondral grafting: a biomechanical study. Am J Sports Med 2004, 32(2):317-320.
17. Grande D.A., Pitman M.I., Peterson L., Menche D., Klein M. The repair of experimentally produced defects in rabbit articular cartilage by autologous chondrocyte transplantation. JOrthop Res 1989, 7(2):208-218.
18. Brittberg M., Lindahl A., Nilsson A., Ohlsson C., Isaksson O., Peterson L. Treatment of deep cartilage defects in the knee with autologous chondrocyte transplantation. NEngl J Med 1994, 331(14):889-895.
19. Vanlauwe J., Saris D.B., Victor J., Almqvist K.F., Bellemans J., Luyten F.P., et al. Five-year outcome of characterized chondrocyte implantation versus microfracture for symptomatic cartilage defects of the knee: early treatment matters. Am J Sports Med 2011, 39(12):2566-2574.
20. Knutsen G., Drogset J.O., Engebretsen L., Grontvedt T., Isaksen V., Ludvigsen T.C., et al. Arandomized trial comparing autologous chondrocyte implantation with microfracture. Findings at five years. JBone Joint Surg Am 2007, 89(10):2105-2112.
21. Peterson L., Vasiliadis H.S., Brittberg M., Lindahl A. Autologous chondrocyte implantation: a long-term follow-up. Am J Sports Med 2010, 38(6):1117-1124.
22. Harris J.D., Siston R.A., Brophy R.H., Lattermann C., Carey J.L., Flanigan D.C. Failures, re-operations, and complications after autologous chondrocyte implantation-a systematic review. Osteoarthritis Cartilage 2011, 19(7):779-791.
23. Dorotka R., Bindreiter U., Macfelda K., Windberger U., Nehrer S. Marrow stimulation and chondrocyte transplantation using a collagen matrix for cartilage repair. Osteoarthritis Cartilage 2005, 13(8):655-664.
24. Breinan H.A., Martin S.D., Hsu H.P., Spector M. Healing of canine articular cartilage defects treated with microfracture, a type-II collagen matrix, or cultured autologous chondrocytes. JOrthop Res 2000, 18(5):781-789.
25. Ahmed N., Gan L., Nagy A., Zheng J., Wang C., Kandel R.A. Cartilage tissue formation using redifferentiated passaged chondrocytes invitro. Tissue Eng 2009, 665-673. Part(3).
26. Ahmed N., Taylor D.W., Wunder J., Nagy A., Gross A.E., Kandel R.A. Passaged human chondrocytes accumulate extracellular matrix when induced by bovine chondrocytes. JTissue Eng Regenerative Med 2010, 4(3):233-241.
27. Albrecht F.H. Closure of joint cartilage defects using cartilage fragments and fibrin glue. Fortschr Med 1983, 101(37):1650-1652.
28. Lu Y., Dhanaraj S., Wang Z., Bradley D.M., Bowman S.M., Cole B.J., et al. Minced cartilage without cell culture serves as an effective intraoperative cell source for cartilage repair. JOrthop Res 2006, 24(6):1261-1270.
29. Farr J., Cole B.J., Sherman S., Karas V. Particulated articular cartilage: CAIS and DeNovo NT. JKnee Surg 2012, 25(1):23-29.
30. Hwang N.S., Varghese S., Puleo C., Zhang Z., Elisseeff J. Morphogenetic signals from chondrocytes promote chondrogenic and osteogenic differentiation of mesenchymal stem cells. JCell Physiol 2007, 212(2):281-284.
31. Dell'Accio F., De B.C., Luyten F.P. Microenvironment and phenotypic stability specify tissue formation by human articular cartilage-derived cells invivo. Exp Cell Res 2003, 287(1):16-27.
32. Hettrich C.M., Crawford D., Rodeo S.A. Cartilage repair: third-generation cell-based technologies-basic science, surgical techniques, clinical outcomes. Sports Med Arthrosc Rev 2008, 16(4):230-235.
33. Kessler M.W., Ackerman G., Dines J.S., Grande D. Emerging technologies and fourth generation issues in cartilage repair. Sports Med Arthrosc Rev 2008, 16(4):246-254.
34. Pittenger M.F., Mackay A.M., Beck S.C., Jaiswal R.K., Douglas R., Mosca J.D., et al. Multilineage potential of adult human mesenchymal stem cells. Science 1999, 284(5411):143-147.
35. Dominici M., Le B.K., Mueller I., Slaper-Cortenbach I., Marini F., Krause D., et al. Minimal criteria for defining multipotent mesenchymal stromal cells. The International Society for Cellular Therapy position statement. Cytotherapy 2006, 8(4):315-317.
36. Aicher W.K., Buhring H.J., Hart M., Rolauffs B., Badke A., Klein G. Regeneration of cartilage and bone by defined subsets of mesenchymal stromal cells - potential and pitfalls. Adv Drug Deliv Rev 2011, 63(4-5):342-351.
37. Battula V.L., Bareiss P.M., Treml S., Conrad S., Albert I., Hojak S., et al. Human placenta and bone marrow derived MSC cultured in serum-free, b-FGF-containing medium express cell surface frizzled-9 and SSEA-4 and give rise to multilineage differentiation. Differentiation 2007, 75(4):279-291.
38. Sakaguchi Y., Sekiya I., Yagishita K., Muneta T. Comparison of human stem cells derived from various mesenchymal tissues: superiority of synovium as a cell source. Arthritis Rheum 2005, 52(8):2521-2529.
39. Shirasawa S., Sekiya I., Sakaguchi Y., Yagishita K., Ichinose S., Muneta T. Invitro chondrogenesis of human synovium-derived mesenchymal stem cells: optimal condition and comparison with bone marrow-derived cells. JCell Biochem 2006, 97(1):84-97.
40. Wakitani S., Okabe T., Horibe S., Mitsuoka T., Saito M., Koyama T., et al. Safety of autologous bone marrow-derived mesenchymal stem cell transplantation for cartilage repair in 41 patients with 45 joints followed for up to 11 years and 5 months. JTissue Eng Regenerative Med 2011, 5(2):146-150.
41. Battula V.L., Treml S., Bareiss P.M., Gieseke F., Roelofs H., de Zwart P., et al. Isolation of functionally distinct mesenchymal stem cell subsets using antibodies against CD56, CD271, and mesenchymal stem cell antigen-1. Haematologica 2009, 94(2):173-184.
42. Nejadnik H., Hui J.H., Feng Choong E.P., Tai B.C., Lee E.H. Autologous bone marrow-derived mesenchymal stem cells versus autologous chondrocyte implantation: an observational cohort study. Am J Sports Med 2010, 38(6):1110-1116.
43. Wakitani S., Nawata M., Tensho K., Okabe T., Machida H., Ohgushi H. Repair of articular cartilage defects in the patello-femoral joint with autologous bone marrow mesenchymal cell transplantation: three case reports involving nine defects in five knees. JTissue Eng Regenerative Med 2007, 1(1):74-79.
44. Thomson J.A., Itskovitz-Eldor J., Shapiro S.S., Waknitz M.A., Swiergiel J.J., Marshall V.S., et al. Embryonic stem cell lines derived from human blastocysts. Science 1998, 282(5391):1145-1147.
45. Heng B.C., Cao T., Lee E.H. Directing stem cell differentiation into the chondrogenic lineage invitro. Stem Cells 2004, 22(7):1152-1167.
46. Hwang N.S., Varghese S., Lee H.J., Zhang Z., Ye Z., Bae J., et al. Invivo commitment and functional tissue regeneration using human embryonic stem cell-derived mesenchymal cells. Proc Natl Acad Sci U S A 2008, 105(52):20641-20646.
47. Toh W.S., Guo X.M., Choo A.B., Lu K., Lee E.H., Cao T. Differentiation and enrichment of expandable chondrogenic cells from human embryonic stem cells invitro. JCell Mol Med 2009, 13(9B):3570-3590.
48. Koay E.J., Hoben G.M., Athanasiou K.A. Tissue engineering with chondrogenically differentiated human embryonic stem cells. Stem Cells 2007, 25(9):2183-2190.
49. Toh W.S., Yang Z., Liu H., Heng B.C., Lee E.H., Cao T. Effects of culture conditions and bone morphogenetic protein 2 on extent of chondrogenesis from human embryonic stem cells. Stem Cells 2007, 25(4):950-960.
50. Wakitani S., Aoki H., Harada Y., Sonobe M., Morita Y., Mu Y., et al. Embryonic stem cells form articular cartilage, not teratomas, in osteochondral defects of rat joints. Cell Transplant 2004, 13(4):331-336.
51. Wakitani S., Takaoka K., Hattori T., Miyazawa N., Iwanaga T., Takeda S., et al. Embryonic stem cells injected into the mouse knee joint form teratomas and subsequently destroy the joint. Rheumatology 2003, 42(1):162-165.
52. Nakajima M., Wakitani S., Harada Y., Tanigami A., Tomita N. Invivo mechanical condition plays an important role for appearance of cartilage tissue in ES cell transplanted joint. JOrthop Res 2008, 26(1):10-17.
53. Toh W.S., Lee E.H., Guo X.M., Chan J.K., Yeow C.H., Choo A.B., et al. Cartilage repair using hyaluronan hydrogel-encapsulated human embryonic stem cell-derived chondrogenic cells. Biomaterials 2010, 31(27):6968-6980.
54. Bai H.Y., Chen G.A., Mao G.H., Song T.R., Wang Y.X. Three step derivation of cartilage like tissue from human embryonic stem cells by 2D-3D sequential culture invitro and further implantation invivo on alginate/PLGA scaffolds. JBiomed Mater Res Part A 2010, 94(2):539-546.
55. Takahashi K., Yamanaka S. Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors. Cell 2006, 126(4):663-676.
56. Robinton D.A., Daley G.Q. The promise of induced pluripotent stem cells in research and therapy. Nature 2012, 481(7381):295-305.
57. Wei Y., Zeng W., Wan R., Wang J., Zhou Q., Qiu S., et al. Chondrogenic differentiation of induced pluripotent stem cells from osteoarthritic chondrocytes in alginate matrix. Eur Cells Mater 2012, 23:1-12.
58. Safran M.R., Kim H., Zaffagnini S. The use of scaffolds in the management of articular cartilage injury. JAm Acad Orthopaedic Surgeons 2008, 16(6):306-311.
59. El-Ayoubi R., DeGrandpre C., DiRaddo R., Yousefi A.M., Lavigne P. Design and dynamic culture of 3D-scaffolds for cartilage tissue engineering. JBiomater Appl 2011, 25(5):429-444.
60. Toh W.S., Lee E.H., Cao T. Potential of human embryonic stem cells in cartilage tissue engineering and regenerative medicine. Stem Cell Rev 2011, 7(3):544-559.
61. Marcacci M., Berruto M., Brocchetta D., Delcogliano A., Ghinelli D., Gobbi A., et al. Articular cartilage engineering with hyalograft C: 3-year clinical results. Clin Orthop Relat Res 2005, 435:96-105.
62. Gille J., Behrens P., Volpi P., de Girolamo L., Reiss E., Zoch W., et al. Outcome of Autologous Matrix Induced Chondrogenesis (AMIC) in cartilage knee surgery: data of the AMIC Registry. Arch Orthop Trauma Surg 2013, 133(1):87-93.
63. Crawford D.C., Heveran C.M., Cannon W.D., Foo L.F., Potter H.G. An autologous cartilage tissue implant NeoCart for treatment of grade III chondral injury to the distal femur: prospective clinical safety trial at 2 years. Am J Sports Med 2009, 37(7):1334-1343.
64. Haddo O., Mahroof S., Higgs D., David L., Pringle J., Bayliss M., et al. The use of chondrogide membrane in autologous chondrocyte implantation. Knee 2004, 11(1):51-55.
65. Grigolo B., Lisignoli G., Piacentini A., Fiorini M., Gobbi P., Mazzotti G., et al. Evidence for redifferentiation of human chondrocytes grown on a hyaluronan-based biomaterial (HYAff 11): molecular, immunohistochemical and ultrastructural analysis. Biomaterials 2002, 23(4):1187-1195.
66. Spiller K.L., Maher S.A., Lowman A.M. Hydrogels for the repair of articular cartilage defects. Tissue Eng Part B Rev 2011, 17(4):281-299.
67. Gomoll A.H. Microfracture and augments. JKnee Surg 2012, 25(1):9-15.
68. McNickle A.G., Provencher M.T., Cole B.J. Overview of existing cartilage repair technology. Sports Med Arthrosc Rev 2008, 16(4):196-201.
69. Shive M.S., Hoemann C.D., Restrepo A., Hurtig M.B., Duval N., Ranger P., et al. BST-CarGel: in situ chondroinduction for cartilage repair. Oper Tech Orthopaedics 2012, 16:271-278.
70. Williams G.M., Klisch S.M., Sah R.L. Bioengineering cartilage growth, maturation, and form. Pediatr Res 2008, 63(5):527-534.
71. Fortier L.A., Barker J.U., Strauss E.J., McCarrel T.M., Cole B.J. The role of growth factors in cartilage repair. Clin Orthop Relat Res 2011, 469(10):2706-2715.
72. Jakob M., Demarteau O., Schafer D., Hintermann B., Dick W., Heberer M., et al. Specific growth factors during the expansion and redifferentiation of adult human articular chondrocytes enhance chondrogenesis and cartilaginous tissue formation invitro. JCell Biochem 2001, 81(2):368-377.
73. Francioli S.E., Martin I., Sie C.P., Hagg R., Tommasini R., Candrian C., et al. Growth factors for clinical-scale expansion of human articular chondrocytes: relevance for automated bioreactor systems. Tissue Eng 2007, 13(6):1227-1234.
74. Kuroda R., Usas A., Kubo S., Corsi K., Peng H., Rose T., et al. Cartilage repair using bone morphogenetic protein 4 and muscle-derived stem cells. Arthritis Rheum 2006, 54(2):433-442.
75. Diekman B.O., Rowland C.R., Lennon D.P., Caplan A.I., Guilak F. Chondrogenesis of adult stem cells from adipose tissue and bone marrow: induction by growth factors and cartilage-derived matrix. Tissue Eng 2010, 523-533. Part(2).
76. Munirah S., Ruszymah B.H., Samsudin O.C., Badrul A.H., Azmi B., Aminuddin B.S. Autologous versus pooled human serum for articular chondrocyte growth. JOrthop Surg 2008, 16(2):220-229.
77. Drengk A., Zapf A., Sturmer E.K., Sturmer K.M., Frosch K.H. Influence of platelet-rich plasma on chondrogenic differentiation and proliferation of chondrocytes and mesenchymal stem cells. Cells Tissues Organs 2009, 189(5):317-326.
78. Lin S.S., Landesberg R., Chin H.S., Lin J., Eisig S.B., Lu H.H. Controlled release of PRP-derived growth factors promotes osteogenic differentiation of human mesenchymal stem cells. Conf Proc Annu Int Conf IEEE Eng Med Biol Soc 2006, 1:4358-4361.
79. Clar C., Cummins E., McIntyre L., Thomas S., Lamb J., Bain L., et al. Clinical and cost-effectiveness of autologous chondrocyte implantation for cartilage defects in knee joints: systematic review and economic evaluation. Health Technol Assess 2005, 9(47).
80. Vasiliadis H.S., Wasiak J., Salanti G. Autologous chondrocyte implantation for the treatment of cartilage lesions of the knee: a systematic review of randomized studies. Knee Surg Sports Traumatol Arthrosc 2010, 18(12):1645-1655.
81. Vavken P., Samartzis D. Effectiveness of autologous chondrocyte implantation in cartilage repair of the knee: a systematic review of controlled trials. Osteoarthritis Cartilage 2010, 18(6):857-863.
82. Harris J.D., Siston R.A., Pan X., Flanigan D.C. Autologous chondrocyte implantation: a systematic review. JBone Joint Surg Am 2010, 92(12):2220-2233.
83. Cole B.J., Farr J., Winalski C.S., Hosea T., Richmond J., Mandelbaum B., et al. Outcomes after a single-stage procedure for cell-based cartilage repair: a prospective clinical safety trial with 2-year follow-up. Am J Sports Med 2011, 39(6):1170-1179.
84. James A.W., Xu Y., Lee J.K., Wang R., Longaker M.T. Differential effects of TGF-beta1 and TGF-beta3 on chondrogenesis in posterofrontal cranial suture-derived mesenchymal cells invitro. Plast Reconstr Surg 2009, 123(1):31-43.
85. Zhang B., Yang S., Sun Z., Zhang Y., Xia T., Xu W., et al. Human mesenchymal stem cells induced by growth differentiation factor 5: an improved self-assembly tissue engineering method for cartilage repair. Tissue Eng Part C Methods 2011, 17(12):1189-1199.
86. Fan J., Gong Y., Ren L., Varshney R.R., Cai D., Wang D.A. Invitro engineered cartilage using synovium-derived mesenchymal stem cells with injectable gellan hydrogels. Acta Biomater 2010, 6(3):1178-1185.
87. Goldberg A.J., Lee D.A., Bader D.L., Bentley G. Autologous chondrocyte implantation. Culture in a TGF-beta-containing medium enhances the re-expression of a chondrocytic phenotype in passaged human chondrocytes in pellet culture. JBone Joint Surg Br 2005, 87(1):128-134.
88. Luyten F.P., Chen P., Paralkar V., Reddi A.H. Recombinant bone morphogenetic protein-4, transforming growth factor-beta 1, and activin A enhance the cartilage phenotype of articular chondrocytes invitro. Exp Cell Res 1994, 210(2):224-229.
89. Sekiya I., Colter D.C., Prockop D.J. BMP-6 enhances chondrogenesis in a subpopulation of human marrow stromal cells. Biochem Biophys Res Commun 2001, 284(2):411-418.
90. Gooch K.J., Blunk T., Courter D.L., Sieminski A.L., Vunjak-Novakovic G., Freed L.E. Bone morphogenetic proteins-2, -12, and -13 modulate invitro development of engineered cartilage. Tissue Eng 2002, 8(4):591-601.
91. Chaipinyo K., Oakes B.W., van Damme M.P. Effects of growth factors on cell proliferation and matrix synthesis of low-density, primary bovine chondrocytes cultured in collagen I gels. JOrthop Res 2002, 20(5):1070-1078.
92. Elisseeff J., McIntosh W., Fu K., Blunk B.T., Langer R. Controlled-release of IGF-I and TGF-beta1 in a photopolymerizing hydrogel for cartilage tissue engineering. JOrthop Res 2001, 19(6):1098-1104.
93. Gaissmaier C., Koh J.L., Weise K. Growth and differentiation factors for cartilage healing and repair. Injury 2008, 39(Suppl 96).
94. Mueller M.B., Blunk T., Appel B., Maschke A., Goepferich A., Zellner J., et al. Insulin is essential for invitro chondrogenesis of mesenchymal progenitor cells and influences chondrogenesis in a dose-dependent manner. Int Orthopaedics 2013, 37(1):153-158.
95. Cuevas P., Burgos J., Baird A. Basic fibroblast growth factor (FGF) promotes cartilage repair invivo. Biochem Biophys Res Commun 1988, 156(2):611-618.
96. Siebert C.H., Miltner O., Weber M., Sopka S., Koch S., Niedhart C. Healing of osteochondral grafts in an ovine model under the influence of bFGF. Arthroscopy 2003, 19(2):182-187.
97. Mandl E.W., Jahr H., Koevoet J.L., van Leeuwen J.P., Weinans H., Verhaar J.A., et al. Fibroblast growth factor-2 in serum-free medium is a potent mitogen and reduces dedifferentiation of human ear chondrocytes in monolayer culture. Matrix Biol 2004, 23(4):231-241.
98. Li X., Ellman M.B., Kroin J.S., Chen D., Yan D., Mikecz K., et al. Species-specific biological effects of FGF-2 in articular cartilage: implication for distinct roles within the FGF receptor family. JCell Biochem 2012, 113(7):2532-2542.
99. Inoue H., Kato Y., Iwamoto M., Hiraki Y., Sakuda M., Suzuki F. Stimulation of cartilage-matrix proteoglycan synthesis by morphologically transformed chondrocytes grown in the presence of fibroblast growth factor and transforming growth factor-beta. JCell Physiol 1989, 138(2):329-337.
100. Kato Y., Iwamoto M. Fibroblast growth factor is an inhibitor of chondrocyte terminal differentiation. JBiol Chem 1990, 265(10):5903-5909.